Jasper Ridge Partners’s Tenaya Therapeutics TNYA Stock Holding History

Jasper Ridge Partners’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.1K	Hold	10,250	–	–	﹤0.01%	143
2025 Q4	$7.29K	Hold	10,250	–	–	﹤0.01%	140
2025 Q3	$16.6K	Hold	10,250	–	–	﹤0.01%	144
2025 Q2	$6.26K	Hold	10,250	–	–	﹤0.01%	148
2025 Q1	$5.84K	Hold	10,250	–	–	﹤0.01%	148
2024 Q4	$14.7K	Hold	10,250	–	–	﹤0.01%	144
2024 Q3	$19.8K	Hold	10,250	–	–	﹤0.01%	143
2024 Q2	$31.8K	Hold	10,250	–	–	﹤0.01%	145
2024 Q1	$53.6K	Hold	10,250	–	–	﹤0.01%	146
2023 Q4	$33.2K	Sell	10,250 -52,718	-84%	-$114K	﹤0.01%	145
2023 Q3	$161K	Hold	62,968	–	–	0.01%	128
2023 Q2	$370K	Hold	62,968	–	–	0.02%	110
2023 Q1	$179K	Hold	62,968	–	–	0.01%	135
2022 Q4	$127K	Buy	62,968 +13,573	+27%	+$33.1K	0.01%	137
2022 Q3	$143K	Buy	49,395 +5,000	+11%	+$23.3K	0.01%	137
2022 Q2	$250K	Hold	44,395	–	–	0.02%	122
2022 Q1	$523K	Hold	44,395	–	–	0.03%	111
2021 Q4	$841K	Buy	44,395 +1,000	+2%	+$21.8K	0.03%	102
2021 Q3	$896K	Buy	+43,395	New	+$932K	0.04%	105

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jasper Ridge Partners's TNYA Position: Q1 2026 in Review

Jasper Ridge Partners held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 10,250 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #143.

Jasper Ridge Partners first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $896K in Q3 2021. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Jasper Ridge Partners held 10,250 shares of Tenaya Therapeutics worth $7.1K as of Q1 2026.
Jasper Ridge Partners left its Tenaya Therapeutics share count unchanged in Q1 2026.
Tenaya Therapeutics made up ﹤0.01% of Jasper Ridge Partners's portfolio in Q1 2026, its #143 holding.
Jasper Ridge Partners first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
Jasper Ridge Partners's Tenaya Therapeutics position peaked at $896K in Q3 2021.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Jasper Ridge Partners's 13F filing for Q1 2026, filed 11 May 2026.